Matches in Nanopublications for { ?s ?p "[To examine whether C9ORF72 expansions could be involved in early-onset Alzheimer's disease (EOAD), we genotyped the hexanucleotide repeat region in a large cohort of 114 EOAD patients who all had positive AD cerebrospinal fluid (CSF) biomarkers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588697.RABPA0ngMWwa1mkm7m6oEe3s4iQk6KD7TfV8KbRxaOAi0130_assertion description "[To examine whether C9ORF72 expansions could be involved in early-onset Alzheimer's disease (EOAD), we genotyped the hexanucleotide repeat region in a large cohort of 114 EOAD patients who all had positive AD cerebrospinal fluid (CSF) biomarkers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588697.RABPA0ngMWwa1mkm7m6oEe3s4iQk6KD7TfV8KbRxaOAi0130_provenance.
- NP673218.RAXXzRKTekkL1YOU9CpBRaSOJ4q08ndlUNlCkhxf_wA3E130_assertion description "[To examine whether C9ORF72 expansions could be involved in early-onset Alzheimer's disease (EOAD), we genotyped the hexanucleotide repeat region in a large cohort of 114 EOAD patients who all had positive AD cerebrospinal fluid (CSF) biomarkers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673218.RAXXzRKTekkL1YOU9CpBRaSOJ4q08ndlUNlCkhxf_wA3E130_provenance.
- assertion description "[To examine whether C9ORF72 expansions could be involved in early-onset Alzheimer's disease (EOAD), we genotyped the hexanucleotide repeat region in a large cohort of 114 EOAD patients who all had positive AD cerebrospinal fluid (CSF) biomarkers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP557978.RA4VFdVfeJrnuSCD1etTRo6Km5zXPvWXrGJcU_3ml0LC8130_assertion description "[To examine whether C9ORF72 expansions could be involved in early-onset Alzheimer's disease (EOAD), we genotyped the hexanucleotide repeat region in a large cohort of 114 EOAD patients who all had positive AD cerebrospinal fluid (CSF) biomarkers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557978.RA4VFdVfeJrnuSCD1etTRo6Km5zXPvWXrGJcU_3ml0LC8130_provenance.
- assertion description "[To examine whether C9ORF72 expansions could be involved in early-onset Alzheimer's disease (EOAD), we genotyped the hexanucleotide repeat region in a large cohort of 114 EOAD patients who all had positive AD cerebrospinal fluid (CSF) biomarkers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To examine whether C9ORF72 expansions could be involved in early-onset Alzheimer's disease (EOAD), we genotyped the hexanucleotide repeat region in a large cohort of 114 EOAD patients who all had positive AD cerebrospinal fluid (CSF) biomarkers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.